162 related articles for article (PubMed ID: 37861912)
1. Generation of Autologous Vascular Endothelial Cells for Patients with Peripheral Artery Disease.
Jiang B; Wang X; Rivera-Bolanos N; Ameer GA
J Cardiovasc Transl Res; 2024 Jun; 17(3):558-569. PubMed ID: 37861912
[TBL] [Abstract][Full Text] [Related]
2. Efficient generation of endothelial cells from induced pluripotent stem cells derived from a patient with peripheral arterial disease.
Boonkaew B; Suwanpitak S; Pattanapanyasat K; Sermsathanasawadi N; Wattanapanitch M
Cell Tissue Res; 2022 Apr; 388(1):89-104. PubMed ID: 35072793
[TBL] [Abstract][Full Text] [Related]
3. A comparison of the pro-angiogenic potential of human induced pluripotent stem cell derived endothelial cells and induced endothelial cells in a murine model of peripheral arterial disease.
Clayton ZE; Yuen GS; Sadeghipour S; Hywood JD; Wong JW; Huang NF; Ng MK; Cooke JP; Patel S
Int J Cardiol; 2017 May; 234():81-89. PubMed ID: 28209385
[TBL] [Abstract][Full Text] [Related]
4. Endothelial progenitor cells as a biological marker of peripheral artery disease.
Bitterli L; Afan S; Bühler S; DiSanto S; Zwahlen M; Schmidlin K; Yang Z; Baumgartner I; Diehm N; Kalka C
Vasc Med; 2016 Feb; 21(1):3-11. PubMed ID: 26511986
[TBL] [Abstract][Full Text] [Related]
5. Number of endothelial progenitor cells in peripheral artery disease as a marker of severity and association with pentraxin-3, malondialdehyde-modified low-density lipoprotein and membrane type-1 matrix metalloproteinase.
Morishita T; Uzui H; Nakano A; Mitsuke Y; Geshi T; Ueda T; Lee JD
J Atheroscler Thromb; 2012; 19(2):149-58. PubMed ID: 22123215
[TBL] [Abstract][Full Text] [Related]
6. Coadministration of endothelial and smooth muscle cells derived from human induced pluripotent stem cells as a therapy for critical limb ischemia.
Park JJ; Kwon YW; Kim JW; Park GT; Yoon JW; Kim YS; Kim DS; Kwon SM; Bae SS; Ko K; Kim CS; Kim JH
Stem Cells Transl Med; 2021 Mar; 10(3):414-426. PubMed ID: 33174379
[TBL] [Abstract][Full Text] [Related]
7. Protein-engineered hydrogels enhance the survival of induced pluripotent stem cell-derived endothelial cells for treatment of peripheral arterial disease.
Foster AA; Dewi RE; Cai L; Hou L; Strassberg Z; Alcazar CA; Heilshorn SC; Huang NF
Biomater Sci; 2018 Feb; 6(3):614-622. PubMed ID: 29406542
[TBL] [Abstract][Full Text] [Related]
8. Endothelial cells derived from human iPSCS increase capillary density and improve perfusion in a mouse model of peripheral arterial disease.
Rufaihah AJ; Huang NF; Jamé S; Lee JC; Nguyen HN; Byers B; De A; Okogbaa J; Rollins M; Reijo-Pera R; Gambhir SS; Cooke JP
Arterioscler Thromb Vasc Biol; 2011 Nov; 31(11):e72-9. PubMed ID: 21836062
[TBL] [Abstract][Full Text] [Related]
9. Vascular Smooth Muscle Cell Derived from IPS Cell of Moyamoya Disease - Comparative Characterization with Endothelial Cell Transcriptome.
Tokairin K; Hamauchi S; Ito M; Kazumata K; Sugiyama T; Nakayama N; Kawabori M; Osanai T; Houkin K
J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105305. PubMed ID: 32992193
[TBL] [Abstract][Full Text] [Related]
10. Antiangiogenic VEGF
Ganta VC; Choi M; Farber CR; Annex BH
Circulation; 2019 Jan; 139(2):226-242. PubMed ID: 30586702
[TBL] [Abstract][Full Text] [Related]
11. Combinatorial extracellular matrix microenvironments promote survival and phenotype of human induced pluripotent stem cell-derived endothelial cells in hypoxia.
Hou L; Coller J; Natu V; Hastie TJ; Huang NF
Acta Biomater; 2016 Oct; 44():188-99. PubMed ID: 27498178
[TBL] [Abstract][Full Text] [Related]
12. Avidity-controlled hydrogels for injectable co-delivery of induced pluripotent stem cell-derived endothelial cells and growth factors.
Mulyasasmita W; Cai L; Dewi RE; Jha A; Ullmann SD; Luong RH; Huang NF; Heilshorn SC
J Control Release; 2014 Oct; 191():71-81. PubMed ID: 24848744
[TBL] [Abstract][Full Text] [Related]
13. Functional characterization of iPSC-derived arterial- and venous-like endothelial cells.
Rosa S; Praça C; Pitrez PR; Gouveia PJ; Aranguren XL; Ricotti L; Ferreira LS
Sci Rep; 2019 Mar; 9(1):3826. PubMed ID: 30846769
[TBL] [Abstract][Full Text] [Related]
14. Reprogramming of Adult Peripheral Blood Cells into Human Induced Pluripotent Stem Cells as a Safe and Accessible Source of Endothelial Cells.
Simara P; Tesarova L; Rehakova D; Farkas S; Salingova B; Kutalkova K; Vavreckova E; Matula P; Matula P; Veverkova L; Koutna I
Stem Cells Dev; 2018 Jan; 27(1):10-22. PubMed ID: 29117787
[TBL] [Abstract][Full Text] [Related]
15. Autologous Cell Therapy for Vascular Regeneration: The Role of Proangiogenic Cells.
Bianconi V; Fallarino F; Mannarino MR; Bagaglia F; Kararoudi MN; Aragona CO; Romani R; Pirro M
Curr Med Chem; 2018; 25(35):4518-4534. PubMed ID: 29022506
[TBL] [Abstract][Full Text] [Related]
16. Vascular Regeneration With New Sources of Endothelial Cells.
Lee S; Lee SJ; Yoon YS
Circ Res; 2019 Jan; 124(1):29-31. PubMed ID: 30605418
[TBL] [Abstract][Full Text] [Related]
17. Generation of functional endothelial cells with progenitor-like features from murine induced pluripotent stem cells.
Kachamakova-Trojanowska N; Nowak W; Szade K; Stepniewski J; Bukowska-Strakova K; Zukowska M; Taha H; Chmura-Skirlinska A; Beilharz M; Dulak J; Jozkowicz A
Vascul Pharmacol; 2016 Nov; 86():94-108. PubMed ID: 27568462
[TBL] [Abstract][Full Text] [Related]
18. Reversible secretome and signaling defects in diabetic mesenchymal stem cells from peripheral arterial disease patients.
Chadid T; Morris A; Surowiec A; Robinson S; Sasaki M; Galipeau J; Pollack BP; Brewster LP
J Vasc Surg; 2018 Dec; 68(6S):137S-151S.e2. PubMed ID: 30104096
[TBL] [Abstract][Full Text] [Related]
19. Disease-specific characteristics of vascular cell adhesion molecule-1 levels in patients with peripheral artery disease.
Edlinger C; Lichtenauer M; Wernly B; Pistulli R; Paar V; Prodinger C; Krizanic F; Thieme M; Kammler J; Jung C; Hoppe UC; Schulze PC; Kretzschmar D
Heart Vessels; 2019 Jun; 34(6):976-983. PubMed ID: 30535754
[TBL] [Abstract][Full Text] [Related]
20. Autologous Granulocyte Colony-Stimulating Factor-Mobilized Peripheral Blood CD34 Positive Cell Transplantation for Hemodialysis Patients with Critical Limb Ischemia: A Prospective Phase II Clinical Trial.
Ohtake T; Mochida Y; Ishioka K; Oka M; Maesato K; Moriya H; Hidaka S; Higashide S; Ioji T; Fujita Y; Kawamoto A; Fukushima M; Kobayashi S
Stem Cells Transl Med; 2018 Nov; 7(11):774-782. PubMed ID: 30059194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
